This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Szlavy, L. Articles by Solti, F. Search for Related Content PubMed PubMed Citation Articles by Szlavy, L. Articles by Solti, F. Social Bookmarking                         What's this?

CLS 2210, Hyaluronidase and the Cardiac Lymphatic System

National Institute of Vascular Surgery, Budapest, Hungary

S. Kubik

Institute of Anatomy, Faculty of Medicine, Zurich, Switzerland

A. de Courten

Scientific Department, OM Laboratories, Geneva, Switzerland

H.J. Hachen

Geneva University Hospital, Geneva, Switzerland

F. Solti

National Institute of Vascular Surgery, Budapest, Hungary

Earlier studies have shown that hyaluronidase exerts a potent influence upon the lymphatic system of the myocardium and that it reduces the size of myocar dial infarcts after coronary occlusion. In this study we compared, in mongrel dogs, the effect of intravenous hyaluronidase or CLS 2210 upon the cardiac lymphatic vessels. We observed that in CLS 2210-treated animals the number of visualized cardiac lymphatic vessels was significantly higher than in the hyal uronidase-treated control group. We have previously demonstrated a cardio- protective effect of hyaluronidase in the treatment of acute myocardial infarction. The present experimental data indicate that intravenous CLS 2210 may have a definite role in the management of acute coronary occlusion. Fur ther studies are needed to confirm these preliminary findings.

Angiology, Vol. 36, No. 7, 452-457 (1985)
DOI: 10.1177/000331978503600707


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Szlavy, I. Repa, I. Lengye, and L. Lamboy Effects of Intravenous Streptokinase and CLS 2210 (Calcium Dobesilate) on the Biochemical Markers of Early Acute Myocardial Infarction: A Historic Comparison with Both Studies Angiology, September 1, 1992; 43(9): 741 - 747. [Abstract] [PDF]

				L. Szlavy, I. Repa, and H. J. Hachen The Influence of CLS 2210 on the Course of Myocardial Infarction: A Pilot Study in Man Angiology, August 1, 1991; 42(8): 639 - 647. [Abstract] [PDF]

				J. R. Casley-Smith A Double-Blind Trial of Calcium Dobesilate in Chronic Venous Insufficiency Angiology, January 1, 1988; 39(10): 853 - 857. [Abstract] [PDF]

				L. Szlavy, K. Koster, A. de Courten, and N. K. Hollenberg Early Disappearance of Lymphatics Draining Ischemic Myocardium in the Dog Angiology, January 1, 1987; 38(1): 73 - 84. [Abstract] [PDF]

				L. Szlavy, I. Repa, Z. Szabo, A. de Courten, and H.J. Hachen Salvage of Ischemic Myocardium by CLS 2210 in the Dog: A Preliminary Double-Blind Study Angiology, January 1, 1987; 38(1): 85 - 91. [Abstract] [PDF]